ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

Spending Bill Expected At White House Any Day Now; NIH Awaits 15% Increase.

October 27, 2000

In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations

May 28, 1993

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008